MACROH2A2 and breast carcinoma: We then investigated mH2A2 levels in two cohorts of patient samples (patients from Icahn School of Medicine Mount Sinai (ISMMS) and Breast Cancer Progression tissue microarrays, TMAs) by immunohistochemistry.